Market Research Logo

Global Travel Vaccines Market Analysis 2017 - Forecast to 2025

Global Travel Vaccines Market Analysis 2017 - Forecast to 2025

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2014 to 2025 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Travel Vaccines Market by Product Type
5.1 Introduction
5.2 Combination Vaccines
5.3 Mono Vaccines
6 Travel Vaccines Market by Type of Uses
6.1 Introduction
6.2 DNA Vaccines
6.3 Attenuated vaccines
6.4 Recombinant vector vaccines
6.5 Conjugate vaccines
6.6 Inactive vaccines
6.7 Subunit vaccines
6.8 Toxoid vaccines
7 Travel Vaccines Market by Application
7.1 Introduction
7.2 Pertussis
7.3 Hepatitis A
7.4 Yellow Fever
7.5 Typhoid Fever
7.6 Hepatitis B
7.7 Tetanus
7.8 Meningococcal Disease
7.9 Poliomyelitis
7.10 Diphtheria
7.11 Increase Immune Compliance
8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of MEA
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Sanofi S.A.
10.2 Pfizer Inc
10.3 GlaxoSmithKline plc
10.4 Merck & Co., Inc
10.5 AstraZeneca
10.6 Abbott
10.7 Janssen Pharmaceuticals
10.8 LG Life Sciences
10.9 Mitsubishi Tanabe Pharma
10.10 Roche
10.11 Shenzhen Kangtai Biological Products
10.12 Takeda Pharmaceutical
10.13 Lupin
10.14 Valeant Pharmaceuticals
10.15 GlycoVaxyn
10.16 Hualan Biological Engineering
10.17 Serum Institute of India
10.18 Indian Immunologicals
10.19 Beijing Minhai Biotechnology
11 Appendix
12 Disclaimer
List of Tables
Table 1 Global Travel Vaccines Market Analysis, by Region, (2016-2025) ($MN)
Table 2 Global Travel Vaccines Market Analysis, by Product Type, (2016-2025) ($MN)
Table 3 Global Travel Vaccines Market Analysis, by Combination Vaccines, (2016-2025) ($MN)
Table 4 Global Travel Vaccines Market Analysis, by Mono Vaccines, (2016-2025) ($MN)
Table 5 Global Travel Vaccines Market Analysis, by Type of Uses, (2016-2025) ($MN)
Table 6 Global Travel Vaccines Market Analysis, by DNA Vaccines, (2016-2025) ($MN)
Table 7 Global Travel Vaccines Market Analysis, by Attenuated vaccines, (2016-2025) ($MN)
Table 8 Global Travel Vaccines Market Analysis, by Recombinant vector vaccines, (2016-2025) ($MN)
Table 9 Global Travel Vaccines Market Analysis, by Conjugate vaccines, (2016-2025) ($MN)
Table 10 Global Travel Vaccines Market Analysis, by Inactive vaccines, (2016-2025) ($MN)
Table 11 Global Travel Vaccines Market Analysis, by Subunit vaccines, (2016-2025) ($MN)
Table 12 Global Travel Vaccines Market Analysis, by Toxoid vaccines, (2016-2025) ($MN)
Table 13 Global Travel Vaccines Market Analysis, by Application, (2016-2025) ($MN)
Table 14 Global Travel Vaccines Market Analysis, by Pertussis, (2016-2025) ($MN)
Table 15 Global Travel Vaccines Market Analysis, by Hepatitis A, (2016-2025) ($MN)
Table 16 Global Travel Vaccines Market Analysis, by Yellow Fever, (2016-2025) ($MN)
Table 17 Global Travel Vaccines Market Analysis, by Typhoid Fever, (2016-2025) ($MN)
Table 18 Global Travel Vaccines Market Analysis, by Hepatitis B, (2016-2025) ($MN)
Table 19 Global Travel Vaccines Market Analysis, by Tetanus, (2016-2025) ($MN)
Table 20 Global Travel Vaccines Market Analysis, by Meningococcal Disease, (2016-2025) ($MN)
Table 21 Global Travel Vaccines Market Analysis, by Poliomyelitis, (2016-2025) ($MN)
Table 22 Global Travel Vaccines Market Analysis, by Diphtheria, (2016-2025) ($MN)
Table 23 Global Travel Vaccines Market Analysis, by Increase Immune Compliance, (2016-2025) ($MN)
Table 24 North America Travel Vaccines Market Analysis, by Country, (2016-2025) ($MN)
Table 25 North America Travel Vaccines Market Analysis, by Product Type, (2016-2025) ($MN)
Table 26 North America Travel Vaccines Market Analysis, by Combination Vaccines, (2016-2025) ($MN)
Table 27 North America Travel Vaccines Market Analysis, by Mono Vaccines, (2016-2025) ($MN)
Table 28 North America Travel Vaccines Market Analysis, by Type of Uses, (2016-2025) ($MN)
Table 29 North America Travel Vaccines Market Analysis, by DNA Vaccines, (2016-2025) ($MN)
Table 30 North America Travel Vaccines Market Analysis, by Attenuated vaccines, (2016-2025) ($MN)
Table 31 North America Travel Vaccines Market Analysis, by Recombinant vector vaccines, (2016-2025) ($MN)
Table 32 North America Travel Vaccines Market Analysis, by Conjugate vaccines, (2016-2025) ($MN)
Table 33 North America Travel Vaccines Market Analysis, by Inactive vaccines, (2016-2025) ($MN)
Table 34 North America Travel Vaccines Market Analysis, by Subunit vaccines, (2016-2025) ($MN)
Table 35 North America Travel Vaccines Market Analysis, by Toxoid vaccines, (2016-2025) ($MN)
Table 36 North America Travel Vaccines Market Analysis, by Application, (2016-2025) ($MN)
Table 37 North America Travel Vaccines Market Analysis, by Pertussis, (2016-2025) ($MN)
Table 38 North America Travel Vaccines Market Analysis, by Hepatitis A, (2016-2025) ($MN)
Table 39 North America Travel Vaccines Market Analysis, by Yellow Fever, (2016-2025) ($MN)
Table 40 North America Travel Vaccines Market Analysis, by Typhoid Fever, (2016-2025) ($MN)
Table 41 North America Travel Vaccines Market Analysis, by Hepatitis B, (2016-2025) ($MN)
Table 42 North America Travel Vaccines Market Analysis, by Tetanus, (2016-2025) ($MN)
Table 43 North America Travel Vaccines Market Analysis, by Meningococcal Disease, (2016-2025) ($MN)
Table 44 North America Travel Vaccines Market Analysis, by Poliomyelitis, (2016-2025) ($MN)
Table 45 North America Travel Vaccines Market Analysis, by Diphtheria, (2016-2025) ($MN)
Table 46 North America Travel Vaccines Market Analysis, by Increase Immune Compliance, (2016-2025) ($MN)
Table 47 Europe Travel Vaccines Market Analysis, by Country, (2016-2025) ($MN)
Table 48 Europe Travel Vaccines Market Analysis, by Product Type, (2016-2025) ($MN)
Table 49 Europe Travel Vaccines Market Analysis, by Combination Vaccines, (2016-2025) ($MN)
Table 50 Europe Travel Vaccines Market Analysis, by Mono Vaccines, (2016-2025) ($MN)
Table 51 Europe Travel Vaccines Market Analysis, by Type of Uses, (2016-2025) ($MN)
Table 52 Europe Travel Vaccines Market Analysis, by DNA Vaccines, (2016-2025) ($MN)
Table 53 Europe Travel Vaccines Market Analysis, by Attenuated vaccines, (2016-2025) ($MN)
Table 54 Europe Travel Vaccines Market Analysis, by Recombinant vector vaccines, (2016-2025) ($MN)
Table 55 Europe Travel Vaccines Market Analysis, by Conjugate vaccines, (2016-2025) ($MN)
Table 56 Europe Travel Vaccines Market Analysis, by Inactive vaccines, (2016-2025) ($MN)
Table 57 Europe Travel Vaccines Market Analysis, by Subunit vaccines, (2016-2025) ($MN)
Table 58 Europe Travel Vaccines Market Analysis, by Toxoid vaccines, (2016-2025) ($MN)
Table 59 Europe Travel Vaccines Market Analysis, by Application, (2016-2025) ($MN)
Table 60 Europe Travel Vaccines Market Analysis, by Pertussis, (2016-2025) ($MN)
Table 61 Europe Travel Vaccines Market Analysis, by Hepatitis A, (2016-2025) ($MN)
Table 62 Europe Travel Vaccines Market Analysis, by Yellow Fever, (2016-2025) ($MN)
Table 63 Europe Travel Vaccines Market Analysis, by Typhoid Fever, (2016-2025) ($MN)
Table 64 Europe Travel Vaccines Market Analysis, by Hepatitis B, (2016-2025) ($MN)
Table 65 Europe Travel Vaccines Market Analysis, by Tetanus, (2016-2025) ($MN)
Table 66 Europe Travel Vaccines Market Analysis, by Meningococcal Disease, (2016-2025) ($MN)
Table 67 Europe Travel Vaccines Market Analysis, by Poliomyelitis, (2016-2025) ($MN)
Table 68 Europe Travel Vaccines Market Analysis, by Diphtheria, (2016-2025) ($MN)
Table 69 Europe Travel Vaccines Market Analysis, by Increase Immune Compliance, (2016-2025) ($MN)
Table 70 Asia Pacific Travel Vaccines Market Analysis, by Country, (2016-2025) ($MN)
Table 71 Asia Pacific Travel Vaccines Market Analysis, by Product Type, (2016-2025) ($MN)
Table 72 Asia Pacific Travel Vaccines Market Analysis, by Combination Vaccines, (2016-2025) ($MN)
Table 73 Asia Pacific Travel Vaccines Market Analysis, by Mono Vaccines, (2016-2025) ($MN)
Table 74 Asia Pacific Travel Vaccines Market Analysis, by Type of Uses, (2016-2025) ($MN)
Table 75 Asia Pacific Travel Vaccines Market Analysis, by DNA Vaccines, (2016-2025) ($MN)
Table 76 Asia Pacific Travel Vaccines Market Analysis, by Attenuated vaccines, (2016-2025) ($MN)
Table 77 Asia Pacific Travel Vaccines Market Analysis, by Recombinant vector vaccines, (2016-2025) ($MN)
Table 78 Asia Pacific Travel Vaccines Market Analysis, by Conjugate vaccines, (2016-2025) ($MN)
Table 79 Asia Pacific Travel Vaccines Market Analysis, by Inactive vaccines, (2016-2025) ($MN)
Table 80 Asia Pacific Travel Vaccines Market Analysis, by Subunit vaccines, (2016-2025) ($MN)
Table 81 Asia Pacific Travel Vaccines Market Analysis, by Toxoid vaccines, (2016-2025) ($MN)
Table 82 Asia Pacific Travel Vaccines Market Analysis, by Application, (2016-2025) ($MN)
Table 83 Asia Pacific Travel Vaccines Market Analysis, by Pertussis, (2016-2025) ($MN)
Table 84 Asia Pacific Travel Vaccines Market Analysis, by Hepatitis A, (2016-2025) ($MN)
Table 85 Asia Pacific Travel Vaccines Market Analysis, by Yellow Fever, (2016-2025) ($MN)
Table 86 Asia Pacific Travel Vaccines Market Analysis, by Typhoid Fever, (2016-2025) ($MN)
Table 87 Asia Pacific Travel Vaccines Market Analysis, by Hepatitis B, (2016-2025) ($MN)
Table 88 Asia Pacific Travel Vaccines Market Analysis, by Tetanus, (2016-2025) ($MN)
Table 89 Asia Pacific Travel Vaccines Market Analysis, by Meningococcal Disease, (2016-2025) ($MN)
Table 90 Asia Pacific Travel Vaccines Market Analysis, by Poliomyelitis, (2016-2025) ($MN)
Table 91 Asia Pacific Travel Vaccines Market Analysis, by Diphtheria, (2016-2025) ($MN)
Table 92 Asia Pacific Travel Vaccines Market Analysis, by Increase Immune Compliance, (2016-2025) ($MN)
Table 93 South America Travel Vaccines Market Analysis, by Country, (2016-2025) ($MN)
Table 94 South America Travel Vaccines Market Analysis, by Product Type, (2016-2025) ($MN)
Table 95 South America Travel Vaccines Market Analysis, by Combination Vaccines, (2016-2025) ($MN)
Table 96 South America Travel Vaccines Market Analysis, by Mono Vaccines, (2016-2025) ($MN)
Table 97 South America Travel Vaccines Market Analysis, by Type of Uses, (2016-2025) ($MN)
Table 98 South America Travel Vaccines Market Analysis, by DNA Vaccines, (2016-2025) ($MN)
Table 99 South America Travel Vaccines Market Analysis, by Attenuated vaccines, (2016-2025) ($MN)
Table 100 South America Travel Vaccines Market Analysis, by Recombinant vector vaccines, (2016-2025) ($MN)
Table 101 South America Travel Vaccines Market Analysis, by Conjugate vaccines, (2016-2025) ($MN)
Table 102 South America Travel Vaccines Market Analysis, by Inactive vaccines, (2016-2025) ($MN)
Table 103 South America Travel Vaccines Market Analysis, by Subunit vaccines, (2016-2025) ($MN)
Table 104 South America Travel Vaccines Market Analysis, by Toxoid vaccines, (2016-2025) ($MN)
Table 105 South America Travel Vaccines Market Analysis, by Application, (2016-2025) ($MN)
Table 106 South America Travel Vaccines Market Analysis, by Pertussis, (2016-2025) ($MN)
Table 107 South America Travel Vaccines Market Analysis, by Hepatitis A, (2016-2025) ($MN)
Table 108 South America Travel Vaccines Market Analysis, by Yellow Fever, (2016-2025) ($MN)
Table 109 South America Travel Vaccines Market Analysis, by Typhoid Fever, (2016-2025) ($MN)
Table 110 South America Travel Vaccines Market Analysis, by Hepatitis B, (2016-2025) ($MN)
Table 111 South America Travel Vaccines Market Analysis, by Tetanus, (2016-2025) ($MN)
Table 112 South America Travel Vaccines Market Analysis, by Meningococcal Disease, (2016-2025) ($MN)
Table 113 South America Travel Vaccines Market Analysis, by Poliomyelitis, (2016-2025) ($MN)
Table 114 South America Travel Vaccines Market Analysis, by Diphtheria, (2016-2025) ($MN)
Table 115 South America Travel Vaccines Market Analysis, by Increase Immune Compliance, (2016-2025) ($MN)
Table 116 Middle East & Africa Travel Vaccines Market Analysis, by Country, (2016-2025) ($MN)
Table 117 Middle East & Africa Travel Vaccines Market Analysis, by Product Type, (2016-2025) ($MN)
Table 118 Middle East & Africa Travel Vaccines Market Analysis, by Combination Vaccines, (2016-2025) ($MN)
Table 119 Middle East & Africa Travel Vaccines Market Analysis, by Mono Vaccines, (2016-2025) ($MN)
Table 120 Middle East & Africa Travel Vaccines Market Analysis, by Type of Uses, (2016-2025) ($MN)
Table 121 Middle East & Africa Travel Vaccines Market Analysis, by DNA Vaccines, (2016-2025) ($MN)
Table 122 Middle East & Africa Travel Vaccines Market Analysis, by Attenuated vaccines, (2016-2025) ($MN)
Table 123 Middle East & Africa Travel Vaccines Market Analysis, by Recombinant vector vaccines, (2016-2025) ($MN)
Table 124 Middle East & Africa Travel Vaccines Market Analysis, by Conjugate vaccines, (2016-2025) ($MN)
Table 125 Middle East & Africa Travel Vaccines Market Analysis, by Inactive vaccines, (2016-2025) ($MN)
Table 126 Middle East & Africa Travel Vaccines Market Analysis, by Subunit vaccines, (2016-2025) ($MN)
Table 127 Middle East & Africa Travel Vaccines Market Analysis, by Toxoid vaccines, (2016-2025) ($MN)
Table 128 Middle East & Africa Travel Vaccines Market Analysis, by Application, (2016-2025) ($MN)
Table 129 Middle East & Africa Travel Vaccines Market Analysis, by Pertussis, (2016-2025) ($MN)
Table 130 Middle East & Africa Travel Vaccines Market Analysis, by Hepatitis A, (2016-2025) ($MN)
Table 131 Middle East & Africa Travel Vaccines Market Analysis, by Yellow Fever, (2016-2025) ($MN)
Table 132 Middle East & Africa Travel Vaccines Market Analysis, by Typhoid Fever, (2016-2025) ($MN)
Table 133 Middle East & Africa Travel Vaccines Market Analysis, by Hepatitis B, (2016-2025) ($MN)
Table 134 Middle East & Africa Travel Vaccines Market Analysis, by Tetanus, (2016-2025) ($MN)
Table 135 Middle East & Africa Travel Vaccines Market Analysis, by Meningococcal Disease, (2016-2025) ($MN)
Table 136 Middle East & Africa Travel Vaccines Market Analysis, by Poliomyelitis, (2016-2025) ($MN)
Table 137 Middle East & Africa Travel Vaccines Market Analysis, by Diphtheria, (2016-2025) ($MN)
Table 138 Middle East & Africa Travel Vaccines Market Analysis, by Increase Immune Compliance, (2016-2025) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report